acp-319
Showing 1 - 1 of 1
Chronic Lymphocytic Leukemia Trial in Columbus, Hermitage, Fort Worth (acalabrutinib, ACP-319)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- acalabrutinib
- ACP-319
-
Columbus, Ohio
- +1 more
Jan 20, 2022